Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15781427rdf:typepubmed:Citationlld:pubmed
pubmed-article:15781427lifeskim:mentionsumls-concept:C0027651lld:lifeskim
pubmed-article:15781427lifeskim:mentionsumls-concept:C0013227lld:lifeskim
pubmed-article:15781427lifeskim:mentionsumls-concept:C1268443lld:lifeskim
pubmed-article:15781427lifeskim:mentionsumls-concept:C0392920lld:lifeskim
pubmed-article:15781427lifeskim:mentionsumls-concept:C0600688lld:lifeskim
pubmed-article:15781427lifeskim:mentionsumls-concept:C0443288lld:lifeskim
pubmed-article:15781427lifeskim:mentionsumls-concept:C1533148lld:lifeskim
pubmed-article:15781427lifeskim:mentionsumls-concept:C2698651lld:lifeskim
pubmed-article:15781427pubmed:issue2lld:pubmed
pubmed-article:15781427pubmed:dateCreated2005-6-29lld:pubmed
pubmed-article:15781427pubmed:abstractTextCancer chemotherapy with the application of several drugs is studied. The negative and inhibiting effect of the tumour on normal cells is taken into account. Under certain hypotheses, we determine the optimal regimen that minimizes the tumour burden at the end of a fixed period of therapy while maintaining several normal cell populations above prescribed levels. More precisely, it is demonstrated that the optimal drug administration corresponds to the strategy of intensive chemotherapy.lld:pubmed
pubmed-article:15781427pubmed:languageenglld:pubmed
pubmed-article:15781427pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15781427pubmed:citationSubsetIMlld:pubmed
pubmed-article:15781427pubmed:statusMEDLINElld:pubmed
pubmed-article:15781427pubmed:monthJunlld:pubmed
pubmed-article:15781427pubmed:issn1477-8599lld:pubmed
pubmed-article:15781427pubmed:authorpubmed-author:SavkinAndrey...lld:pubmed
pubmed-article:15781427pubmed:authorpubmed-author:MatveevAlexey...lld:pubmed
pubmed-article:15781427pubmed:issnTypePrintlld:pubmed
pubmed-article:15781427pubmed:volume22lld:pubmed
pubmed-article:15781427pubmed:ownerNLMlld:pubmed
pubmed-article:15781427pubmed:authorsCompleteYlld:pubmed
pubmed-article:15781427pubmed:pagination143-62lld:pubmed
pubmed-article:15781427pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:15781427pubmed:meshHeadingpubmed-meshheading:15781427...lld:pubmed
pubmed-article:15781427pubmed:meshHeadingpubmed-meshheading:15781427...lld:pubmed
pubmed-article:15781427pubmed:meshHeadingpubmed-meshheading:15781427...lld:pubmed
pubmed-article:15781427pubmed:meshHeadingpubmed-meshheading:15781427...lld:pubmed
pubmed-article:15781427pubmed:meshHeadingpubmed-meshheading:15781427...lld:pubmed
pubmed-article:15781427pubmed:year2005lld:pubmed
pubmed-article:15781427pubmed:articleTitleInfluence of tumours on normal cells and optimal chemotherapy regimens: the case of several drugs and toxicity constraints.lld:pubmed
pubmed-article:15781427pubmed:affiliationSchool of Electrical Engineering and Telecommunications, The University of New South Wales, Sydney 2052, Australia. alexeymatveev@hotmail.comlld:pubmed
pubmed-article:15781427pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15781427pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed